ASHP Advantage Podcasts

Julie Golembiewski conducts a roundtable discussion with Virginia Ghafoor and Leslie Schechter about the benefits of using multimodal therapy for managing postoperative pain. The roundtable was conducted in December 2013 during the ASHP Midyear Clinical Meeting. Faculty: Julie Golembiewski, Pharm.D., FASHP, Activity Chair Clinical Pharmacist, Anesthesia and Pain University of Illinois Hospital and Health Sciences System Clinical Associate Professor Colleges of Pharmacy and Medicine University of Illinois at Chicago Chicago, Illinois Virginia L. Ghafoor, Pharm.D. Pharmacy Specialist, Pain Management University of Minnesota Medical Center Minneapolis, Minnesota Leslie N. Schechter, Pharm.D. Advanced Practice Pharmacist, Pain Management and Nutritional Support Thomas Jefferson University Hospital Clinical Assistant Professor Philadelphia College of Pharmacy University of the Sciences Philadelphia, Pennsylvania C.E. Credits: This activity is not eligible for continuing education credits.

Julie Golembiewski conducts a roundtable discussion with Virginia Ghafoor and Leslie Schechter about the benefits of using multimodal therapy for managing postoperative pain. The roundtable was conducted in December 2013 during the ASHP Midyear Clinical Meeting. Faculty: Julie Golembiewski, Pharm.D., FASHP, Activity Chair Clinical Pharmacist, Anesthesia and Pain University of Illinois Hospital and Health Sciences System Clinical Associate Professor Colleges of Pharmacy and Medicine University of Illinois at Chicago Chicago, Illinois Virginia L. Ghafoor, Pharm.D. Pharmacy Specialist, Pain Management University of Minnesota Medical Center Minneapolis, Minnesota Leslie N. Schechter, Pharm.D. Advanced Practice Pharmacist, Pain Management and Nutritional Support Thomas Jefferson University Hospital Clinical Assistant Professor Philadelphia College of Pharmacy University of the Sciences Philadelphia, Pennsylvania C.E. Credits: This activity is not eligible for continuing education credits.

Joseph Dasta conducts a roundtable discussion with Amy Dzierba and Jodie Pepin about the role of pharmacists in managing hyponatremia in hospitalized patients, including considerations related to transition of care after discharge. The interview was conducted in December 2013 during the ASHP Midyear Clinical Meeting. Faculty: Joseph F. Dasta, M.S., FCCM, FCCP, Activity Chair Professor Emeritus The Ohio State University College of Pharmacy Adjunct Professor The University of Texas College of Pharmacy Austin, Texas Amy L. Dzierba, Pharm.D., BCPS, FCCM Clinical Pharmacist, Adult Critical Care New York-Presbyterian Hospital Lecturer Columbia University School of Nursing New York, New York Jodie L. Pepin, Pharm.D. Director of Pharmacy Seton Medical Center Williamson Seton Healthcare Family Clinical Assistant Professor of Health Outcomes and Pharmacy Practice The University of Texas College of Pharmacy Austin, Texas C.E. Credits: This activity is not eligible for continuing education credits.

Joseph Dasta conducts a roundtable discussion with Amy Dzierba and Jodie Pepin about managing hyponatremia in critically ill patients, especially factors affecting the rate of serum sodium correction. The interview was conducted in December 2013 during the ASHP Midyear Clinical Meeting. Faculty: Joseph F. Dasta, M.S., FCCM, FCCP, Activity Chair Professor Emeritus The Ohio State University College of Pharmacy Adjunct Professor The University of Texas College of Pharmacy Austin, Texas Amy L. Dzierba, Pharm.D., BCPS, FCCM Clinical Pharmacist, Adult Critical Care New York-Presbyterian Hospital Lecturer Columbia University School of Nursing New York, New York Jodie L. Pepin, Pharm.D. Director of Pharmacy Seton Medical Center Williamson Seton Healthcare Family Clinical Assistant Professor of Health Outcomes and Pharmacy Practice The University of Texas College of Pharmacy Austin, Texas C.E. Credits: This activity is not eligible for continuing education credits.

Joseph Dasta conducts a roundtable discussion with Amy Dzierba and Jodie Pepin about considerations in developing protocols for managing hospitalized patients with hyponatremia. The roundtable was conducted in December 2013 during the ASHP Midyear Clinical Meeting. Faculty: Joseph F. Dasta, M.S., FCCM, FCCP, Activity Chair Professor Emeritus The Ohio State University College of Pharmacy Adjunct Professor The University of Texas College of Pharmacy Austin, Texas Amy L. Dzierba, Pharm.D., BCPS, FCCM Clinical Pharmacist, Adult Critical Care New York-Presbyterian Hospital Lecturer Columbia University School of Nursing New York, New York Jodie L. Pepin, Pharm.D. Director of Pharmacy Seton Medical Center Williamson Seton Healthcare Family Clinical Assistant Professor of Health Outcomes and Pharmacy Practice The University of Texas College of Pharmacy Austin, Texas C.E. Credits: This activity is not eligible for continuing education credits.

Paul Szumita discusses with Carla Brink, Scientific Project Director for ASHP, considerations for managing hyperglycemia in hospitalized patients who are critically ill, do or do not have a previous diagnosis of diabetes mellitus, or are receiving parenteral or enteral nutrition. The interview was conducted in December 2013 during the ASHP Midyear Clinical Meeting. Faculty: Paul M. Szumita, Pharm.D., BCPS Clinical Pharmacy Practice Manager Director, Critical Care Pharmacy Residency Brigham and Women’s Hospital Boston, Massachusetts C.E. Credits: This activity is not eligible for continuing education credits.

Kevin Box discusses with Carla Brink, Scientific Project Director for ASHP, what metrics to collect and then how to use them to facilitate improvements in glycemic control for hospitalized patients. The interview was conducted in December 2013 during the ASHP Midyear Clinical Meeting. Faculty: Kevin W. Box, Pharm.D. Senior Clinical Pharmacist UC San Diego Health System San Diego, California C.E. Credits: This activity is not eligible for continuing education credits.

Curtis Triplitt discusses with Carla Brink, Scientific Project Director for ASHP, recommended target glucose levels in guidelines for inpatient glycemic control. The interview was conducted in December 2013 during the ASHP Midyear Clinical Meeting. Faculty: Curtis L. Triplitt, Pharm.D., CDE, Activity Chair Associate Director, Diabetes Research Center, Texas Diabetes Institute Associate Professor, Department of Medicine, Division of Diabetes University of Texas Health Science Center at San Antonio San Antonio, Texas C.E. Credits: This activity is not eligible for continuing education credits.

Challenges in Managing Acute Bleeding in Patients with Hemophilia (Part 1 of 3) Part 1: Monitoring and Dosing Considerations Faculty: William E. Dager, Pharm.D., BCPS (AQ-Cardiology) Pharmacist Specialist UC Davis Medical Center Sacramento, California Mark T. Reding, M.D. Director, Center for Bleeding and Clotting Disorders University of Minnesota Medical Center, Fairview Associate Professor University of Minnesota Medical School Minneapolis, Minnesota C.E. Credits: This activity is not eligible for continuing education credits.

Challenges in Managing Acute Bleeding in Patients with Hemophilia (Part 2 of 3) Part 2: Considerations in Controlling Bleeding and Preventing Thrombosis Faculty: William E. Dager, Pharm.D., BCPS (AQ-Cardiology) Pharmacist Specialist UC Davis Medical Center Sacramento, California Mark T. Reding, M.D. Director, Center for Bleeding and Clotting Disorders University of Minnesota Medical Center, Fairview Associate Professor University of Minnesota Medical School Minneapolis, Minnesota C.E. Credits: This activity is not eligible for continuing education credits.

Challenges in Managing Acute Bleeding in Patients with Hemophilia (Part 1 of 3) Part 3: Monitoring and Dosing Considerations Faculty: William E. Dager, Pharm.D., BCPS (AQ-Cardiology) Pharmacist Specialist UC Davis Medical Center Sacramento, California Surabhi Palkimas, Pharm.D. Pharmacy Clinical Coordinator, Hematology University of Virginia Health System Charlottesville, Virginia C.E. Credits: This activity is not eligible for continuing education credits.

Emerging Treatment Options for the Reversal of Oral Anticoagulant Therapy - Faculty Roundtable Discussion (Part 1 of 3) Part 1: Issues Related to Warfarin Reversal Faculty: Edith A. Nutescu, Pharm.D., FCCP, Chair and Moderator Clinical Professor The University of Illinois at Chicago College of Pharmacy Director, Antithrombosis Center The University of Illinois Hospital and Health Sciences System Chicago, Illinois William E. Dager, Pharm.D., BCPS (AQ-Cardiology) Pharmacist Specialist UC Davis Medical Center Sacramento, California James S. Kalus, Pharm.D., BCPS (AQ-Cardiology) Senior Manager, Patient Care Services Department of Pharmacy Services Henry Ford Hospital C.E. Credits: This activity is not eligible for continuing education credits.

Emerging Treatment Options for the Reversal of Oral Anticoagulant Therapy - Faculty Roundtable Discussion (Part 2 of 4) Part 2: Usefulness of Coagulation Assays in Patients taking Target-Specific Oral Anticoagulants Faculty: Edith A. Nutescu, Pharm.D., FCCP, Chair and Moderator Clinical Professor The University of Illinois at Chicago College of Pharmacy Director, Antithrombosis Center The University of Illinois Hospital and Health Sciences System Chicago, Illinois William E. Dager, Pharm.D., BCPS (AQ-Cardiology) Pharmacist Specialist UC Davis Medical Center Sacramento, California James S. Kalus, Pharm.D., BCPS (AQ-Cardiology) Senior Manager, Patient Care Services Department of Pharmacy Services Henry Ford Hospital C.E. Credits: This activity is not eligible for continuing education credits.

Emerging Treatment Options for the Reversal of Oral Anticoagulant Therapy - Faculty Roundtable Discussion (Part 3 of 4) Part 3: Balancing Bleeding and Thrombosis Risk Faculty: Edith A. Nutescu, Pharm.D., FCCP, Chair and Moderator Clinical Professor The University of Illinois at Chicago College of Pharmacy Director, Antithrombosis Center The University of Illinois Hospital and Health Sciences System Chicago, Illinois William E. Dager, Pharm.D., BCPS (AQ-Cardiology) Pharmacist Specialist UC Davis Medical Center Sacramento, California James S. Kalus, Pharm.D., BCPS (AQ-Cardiology) Senior Manager, Patient Care Services Department of Pharmacy Services Henry Ford Hospital C.E. Credits: This activity is not eligible for continuing education credits.

Emerging Treatment Options for the Reversal of Oral Anticoagulant Therapy - Faculty Roundtable Discussion (Part 4 of 4) Part 4: Reversal of Target-specific Oral Anticoagulants Faculty: Edith A. Nutescu, Pharm.D., FCCP, Chair and Moderator Clinical Professor The University of Illinois at Chicago College of Pharmacy Director, Antithrombosis Center The University of Illinois Hospital and Health Sciences System Chicago, Illinois William E. Dager, Pharm.D., BCPS (AQ-Cardiology) Pharmacist Specialist UC Davis Medical Center Sacramento, California James S. Kalus, Pharm.D., BCPS (AQ-Cardiology) Senior Manager, Patient Care Services Department of Pharmacy Services Henry Ford Hospital C.E. Credits: This activity is not eligible for continuing education credits.